The primary RAGE ligands constitute a heterogeneous class of structures formed via non-enzymatic glycosylation, advanced glycation end-products (AGE, Figure 2) (8), that increase in circulation during CKD (9). This evidence concerns the gene AGER and chronic kidney disease.